Accéder au contenu
Merck

Inflammation Triggers Liver X Receptor-Dependent Lipogenesis.

Molecular and cellular biology (2019-10-30)
Sophie R Liebergall, Jerry Angdisen, Shun Hang Chan, YingJu Chang, Timothy F Osborne, Alexander F Koeppel, Stephen D Turner, Ira G Schulman
RÉSUMÉ

Immune cell function can be modulated by changes in lipid metabolism. Our studies indicate that cholesterol and fatty acid synthesis increases in macrophages between 12 and 18 h after the activation of Toll-like receptors with proinflammatory stimuli and that the upregulation of lipogenesis may contribute to the resolution of inflammation. The inflammation-dependent increase in lipogenesis requires the induction of the liver X receptors, members of the nuclear receptor superfamily of transcription factors, by type I interferons in response to inflammatory signals. Instead of the well-established role for liver X receptors in stimulating cholesterol efflux, we demonstrate that liver X receptors are necessary for the proper resumption of cholesterol synthesis in response to inflammatory signals. Thus, liver X receptors function as bidirectional regulators of cholesterol homeostasis, driving efflux when cholesterol levels are high and facilitating synthesis in response to inflammatory signals. Liver X receptor activity is also required for the proper shutdown of a subset of type I interferon-stimulated genes as inflammation subsides, placing the receptors in a negative-feedback loop that may contribute to the resolution of the inflammatory response.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Avanti
Kdo2-Lipid A (KLA), Avanti Research - A Croda Brand